These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3888982)

  • 1. Covalent linkage of 125I-insulin to a cytosolic insulin-degrading enzyme.
    Shii K; Baba S; Yokono K; Roth RA
    J Biol Chem; 1985 Jun; 260(11):6503-6. PubMed ID: 3888982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo association of [125I]-insulin with a cytosolic insulin-degrading enzyme: detection by covalent cross-linking and immunoprecipitation with a monoclonal antibody.
    Hari J; Shii K; Roth RA
    Endocrinology; 1987 Feb; 120(2):829-31. PubMed ID: 3026782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-degrading enzyme is capable of degrading receptor-bound insulin.
    Yonezawa K; Yokono K; Shii K; Hari J; Yaso S; Amano K; Sakamoto T; Kawase Y; Akiyama H; Nagata M
    Biochem Biophys Res Commun; 1988 Jan; 150(2):605-14. PubMed ID: 3277630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demonstration of specific insulin binding to cytosolic proteins in H35 hepatoma cells, rat liver and skeletal muscle.
    Harada S; Smith RM; Smith JA; Shah N; Jarett L
    Biochem J; 1995 Feb; 306 ( Pt 1)(Pt 1):21-8. PubMed ID: 7864812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of insulin degradation by hepatoma cells after microinjection of monoclonal antibodies to a specific cytosolic protease.
    Shii K; Roth RA
    Proc Natl Acad Sci U S A; 1986 Jun; 83(12):4147-51. PubMed ID: 2424018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [125I]-insulin metabolism by the rat liver in vivo: evidence that a neutral thiol-protease mediates rapid intracellular insulin degradation.
    Williams FG; Johnson DE; Bauer GE
    Metabolism; 1990 Mar; 39(3):231-41. PubMed ID: 2407925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human red blood cell insulin-degrading enzyme and rat skeletal muscle insulin protease share antigenic sites and generate identical products from insulin.
    Duckworth WC; Hamel FG; Bennett R; Ryan MP; Roth RA
    J Biol Chem; 1990 Feb; 265(5):2984-7. PubMed ID: 1689296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rat brain insulin degrading enzyme in insulin and thyroid hormones imbalances.
    Azam M; Gupta BL; Gupta G; Jain S; Baquer NZ
    Biochem Int; 1990; 21(2):321-9. PubMed ID: 2206136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Kinetic studies of insulin degrading enzyme in cultured human lymphocytes].
    Yaso S
    Nihon Naibunpi Gakkai Zasshi; 1988 Apr; 64(4):289-302. PubMed ID: 3042472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and characterization of insulin-degrading enzyme from pig skeletal muscle.
    Yokono K; Imamura Y; Shii K; Sakai H; Baba S
    Endocrinology; 1981 Apr; 108(4):1527-32. PubMed ID: 7009152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 125I-labelled insulin degradation by isolated rat hepatocytes: the roles of glutathione-insulin transhydrogenase and insulin-specific protease.
    Poole GP; O'Connor KJ; Lazarus NR; Pogson CI
    Diabetologia; 1982 Jul; 23(1):49-53. PubMed ID: 6749584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Affinity purification of insulin-degrading enzyme and its endogenous inhibitor from rat liver.
    Ogawa W; Shii K; Yonezawa K; Baba S; Yokono K
    J Biol Chem; 1992 Jan; 267(2):1310-6. PubMed ID: 1730651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drosophila insulin degrading enzyme and rat skeletal muscle insulin protease cleave insulin at similar sites.
    Duckworth WC; Garcia JV; Liepnieks JJ; Hamel FG; Hermodson MA; Frank BH; Rosner MR
    Biochemistry; 1989 Mar; 28(6):2471-7. PubMed ID: 2659071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms involved in degradation of human insulin by cytosolic fractions of human, monkey, and rat liver.
    Wroblewski VJ; Masnyk M; Khambatta SS; Becker GW
    Diabetes; 1992 Apr; 41(4):539-47. PubMed ID: 1607078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological properties of an initial degradation product of insulin by insulin-degrading enzyme.
    Yonezawa K; Yokono K; Shii K; Hari J; Yaso S; Sakamoto T; Kawase Y; Akiyama H; Taketomi S; Baba S
    Endocrinology; 1989 Jan; 124(1):496-504. PubMed ID: 2642422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degradation of insulin-like growth factors I and II by a human insulin degrading enzyme.
    Roth RA; Mesirow ML; Yokono K; Baba S
    Endocr Res; 1984; 10(2):101-12. PubMed ID: 6389104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degradation of soluble amyloid beta-peptides 1-40, 1-42, and the Dutch variant 1-40Q by insulin degrading enzyme from Alzheimer disease and control brains.
    Pérez A; Morelli L; Cresto JC; Castaño EM
    Neurochem Res; 2000 Feb; 25(2):247-55. PubMed ID: 10786709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degradation products of insulin generated by hepatocytes and by insulin protease.
    Duckworth WC; Hamel FG; Peavy DE; Liepnieks JJ; Ryan MP; Hermodson MA; Frank BH
    J Biol Chem; 1988 Feb; 263(4):1826-33. PubMed ID: 3276679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of the substance immunologically cross-reactive with insulin in insulin RIA is an artifact caused by insulin tracer degradation: involvement of the insulin-degrading enzyme.
    Saric T; Seitz HJ; Pavelic K
    Mol Cell Endocrinol; 1994 Dec; 106(1-2):23-9. PubMed ID: 7895911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of a mutant insulin by a receptor-mediated process and an insulin degrading enzyme.
    Kobayashi M; Iwasaki M; Watanabe N; Ishibashi O; Takata Y; Haruta T; Sasaoka T; Shigeta Y; Inouye K
    Diabetes Res Clin Pract; 1986; 2(5):257-62. PubMed ID: 3536368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.